Plasma insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, and the risk of prostate cancer: A matched case-control study in a Korean population

Korean Journal of Urology

Volumn 50, Issue 7, 2009, Pages 642-648

  Jeong, Hyun Kim ^a   Kwan, Jin Park ^b   Bae, Jung Bum ^b   Woon, Geol Yeo ^b   Byun, Seok Soo ^b   Eun, Sik Lee ^b  

^a Kangwon National University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Insulin like growth factor binding protein 3; Insulin like growth factor I; Prostatic neoplasms

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CANCER RISK; CONTROLLED STUDY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

EID: 68449084670     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2009.50.7.642     Document Type: Article

References (24)

1. Fürstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002;3:298-302
2. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-320
3. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, et al. Plasmainsulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;79: 63-66 (Pubitemid 28067285)
4. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 1997;76:1115-1118 (Pubitemid 27448004)
5. Leal SM, Liu Q, Huang SS, Huang JS. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem 1997; 72:20572-20576 (Pubitemid 27355615)
6. Schedlich LJ, Le Page SL, Firth SM, Briggs LI, Jans DA, Baxter RC. Nuclear import of insulin-like growth factor- inding protein-3 and -5 is mediated by the importin beta subunit. J Biol Chem 2000;275:23462-23470
7. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, et al. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 2000;275:33607-33613 (Pubitemid 30808578)
8. Boyle BJ, Zhao XY, Cohen P, Feldman D. Insulin-like growth factor binding protein-3 mediates 1 alpha, 25-dihydroxyvitamin D(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. J Urol 2001;165:1319-1324
9. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995;377:646-649
10. Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, et al. Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 2001;10:421-427 (Pubitemid 32701626)
11. Stattin P, Bylund A, Rinaldi S, Biessy C, Déchaud H, Stenman UH, et al. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 2000;92:1910-1917 (Pubitemid 32036921)
12. Harman SM, Metter EJ, Blackman MR, Landis PK, Carter HB. Baltimore Longitudinal Study on Aging. Serum levels of insulin- like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 2000;85:4258-4265
13. Wolk A, Mantzoros CS, Andersson SO, Bergström R, Signorello LB, Lagiou P, et al. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 1998;90:911-915
14. Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, et al. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1137-1141
15. Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin. Cancer 2005; 103:76-84 (Pubitemid 39665459)
16. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein- 3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-1353
17. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969-974 (Pubitemid 28445094)
18. Wang L, Habuchi T, Tsuchiya N, Mitsumori K, Ohyama C, Sato K, et al. Insulin-like growth factor-binding protein-3 gene - 202 A/C polymorphism is correlated with advanced disease status in prostate cancer. Cancer Res 2003;63:4407-4411 (Pubitemid 36951011)
19. Moon JW, Chang YS, Ahn CW, Yoo KN, Shin JH, Kong JH, et al. Promoter -202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk. Int J Cancer 2006;118:353-356
20. Shariat SF, Lamb DJ, Kattan MW, Nguyen C, Kim J, Beck J, et al. Association of preoperative plasma levels of insulin- like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. J Clin Oncol 2002;20:833-841 (Pubitemid 34111393)
21. Kim YJ, Chang IH, Gil MC, Hong SK, Byun SS, Lee SE. Concordance of Gleason scores between prostate needle biopsy and radical prostatectomy specimens according to the number of biopsy cores. Korean J Urol 2006;47:482-488
22. Chung JS, Han BK, Jeong SJ, Hong SK, Byun SS, Choe G, et al. Pathologic outcome of unilateral low risk prostate cancers on multicore prostate biopsy after radical prostatectomy. Korean J Urol 2008;49:874-878
23. Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, van Doom J, et al. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. Clin Lab Anal 1999;13:166-172 (Pubitemid 29309773)
24. Goodman-Gruen D, Barrett-Connor E. Epidemiology of insulin- like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 1997;145:970-976 (Pubitemid 27215479)